Burnett, Alan K <br/><br/>
The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA.  [electronic resource] 

 -  Blood  Feb 2010 
 - 948-56 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2009-08-236588  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>CCAAT-Enhancer-Binding Proteins--genetics<br/>Child<br/>Child, Preschool<br/>Cytarabine--administration & dosage<br/>Daunorubicin--administration & dosage<br/>Female<br/>Gene Expression Regulation, Leukemic<br/>Genotype<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Leukemia, Promyelocytic, Acute--drug therapy<br/>Male<br/>Middle Aged<br/>Mutation<br/>Nuclear Proteins--genetics<br/>Nucleophosmin<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Thioguanine--administration & dosage<br/>Treatment Outcome<br/>Tretinoin--administration & dosage<br/>Young Adult<br/>fms-Like Tyrosine Kinase 3--genetics